Reversine

CAS No. 656820-32-5

Reversine( Reversine. )

Catalog No. M15499 CAS No. 656820-32-5

Reversine, a small synthetic purine analogue (2,6-disubstituted purine), is a potent inhibitior of Aurora A/B/C with IC50s of 150-500 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 61 In Stock
2MG 43 In Stock
5MG 61 In Stock
10MG 77 In Stock
25MG 159 In Stock
50MG 219 In Stock
100MG 384 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Reversine
  • Note
    Research use only, not for human use.
  • Brief Description
    Reversine, a small synthetic purine analogue (2,6-disubstituted purine), is a potent inhibitior of Aurora A/B/C with IC50s of 150-500 nM.
  • Description
    Reversine, a small synthetic purine analogue (2,6-disubstituted purine), is a potent inhibitior of Aurora A/B/C with IC50s of 150-500 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Reversine.
  • Pathway
    Apoptosis
  • Target
    Adenosine Receptor
  • Recptor
    A3| Aurora A| Aurora B| Aurora C
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    656820-32-5
  • Formula Weight
    393.49
  • Molecular Formula
    C21H27N7O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 5 mg/mL warmed (12.71 mM)
  • SMILES
    C1CCC(CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2[nH]cnc12
  • Chemical Name
    N6-cyclohexyl-N2-(4-morpholinophenyl)-7H-purine-2,6-diamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.D'Alise AM, et al. Mol Y Ther. 2008, 7(5), 1140-1149.
molnova catalog
related products
  • Tonapofylline

    A potent, selective and orally bioavailable adenosine A1 (A1A) receptor antagonist with Ki of 7 nM.

  • ZM-241385

    ZM-241385 is a potent, non-xanthine A2A selective adenosine receptor antagonist with rat PC12 binding pIC50 of 9.52.

  • ST-1535

    A potent, selective A2A adenosine receptor antagonist with Ki of 6.6 nM.